Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4400-4405

  Boerman, Otto C ^a   Kranenborg, Marion H G C ^a   Oosterwijk, Egbert ^a   Griffiths, Gary L ^b   McBride, William J ^b   Oyen, Wim J G ^a   De Weijert, Mirjam ^a   Oosterwijk Wakka, Jeannette ^a   Hansen, Hans J ^b   Corstens, Frans H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IMMUNOMEDICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATE; PENTETATE INDIUM IN 111;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DISTRIBUTION; DRUG TARGETING; ISOTOPE LABELING; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOTHERAPY;

ANIMALS; CARCINOMA, RENAL CELL; INDIUM RADIOISOTOPES; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; PENTETIC ACID; RADIOIMMUNODETECTION; TISSUE DISTRIBUTION;

EID: 0033199028     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Knox, S. J., Goris, M. L., Trisler, K., Negrin, R., Davis, T., Liles, T. M., Grillo-Lopez, A., Chinn, P., Varns, C., Ning, S. C., Fowler, S., Deb, N., Becker, M., Marquez, C., and Levy, R. Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin. Cancer Res., 2: 457-470, 1996.
2. Liu, S. Y., Eary, J. F., Petersdorf, S. H., Martin, P. J., Maloney, D. G., Appelbaum, F. R., Matthews, D. C., Bush, S. A., Durack, L. D., Fisher, D. R., Gooley, T. A., Bernstein, I. D., and Press, O. W. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J. Clin. Oncol., 16: 3270-3278, 1988.
3. Jurcic, J. G., and Scheinberg, D. A. Radioimmunotherapy of hematological cancer: problems and progress. Clin. Cancer Res., 1: 1439-1446, 1995.
4. Wilder, R. B., DeNardo, G. L., and DeNardo, S. J. Radioimmunotherapy: recent results and future directions. J. Clin. Oncol, 14: 1383-1400, 1996.
5. Goodwin, D. A., Mears, C. F., McTigue, M., and David, G. S. Monoclonal antibody hapten radiopharmaceutical delivery. Nucl. Med. Commun., 7: 569-580, 1986.
6. Kranenborg, M. H. G. C., Boerman, O. C., Oosterwijk-Wakka, J. C., de Weijert, M. C. A., Corstens, F. H. M., and Oosterwijk, E. Two-step radioimmunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies. Int. J. Cancer, 75: 74-80, 1998.
7. Le Doussal, J-M., Gruaz-Guyon, A., Martin, M., Gautherot, E., Delaage, M., and Barbet, J. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res., 50: 3445-3452, 1990.
8. Gautherot, E., Bouhou, J., Le Doussal, J-M., Manetti, M., Martin, M., Rouvier, E., and Barbet, J. Therapy for colon carcinoma xenografts with bispecific antibodytargeted, iodine-131-labeled bivalent hapten. Cancer (Phila.), 80: 2618-2623, 1997.
9. Gautherot, E., Le Doussal, J. M., Bouhou, J., Manetti, C., Martin, M., Rouvier, E., and Barbet, J. Delivery of therapeutic doses of radioiodine using bispecific antibodytargeted bivalent haptens. J. Nucl. Med., 39: 1937-1943, 1998.
10. Kraeber-Bodéré, F., Faivre-Chauvet, A., Sai-Maurel, C., Gautherot, E., Fiche, M., Campion, L., Le Boterff, J., Barbet, J., Chatal, J-F., and Thedrez, P. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft. J. Nucl. Med., 40: 198-204, 1999.
11. Oosterwijk, E., Ruiter, D. J., Hoedemaeker, P. J., Pauwels, E. K., Jonas, U., Zwartendijk, J., and Warnaar, S. O. Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int. J. Cancer, 38: 489-494, 1986.
12. Oosterwijk, E., De Weijert, M., Van Bokhoven, A., Brakenhoff, R. H., Peelen, W. P., and Debruyne, F. M. J. Molecular characterization of the renal cell carcinoma associated antigen G250. Urol. Res., 23: 253, 1995.
13. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zat'ovicova, M., Liao, S., Portetelle, D., and Stanbridge, E. J. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene, 9: 2877-2888, 1994.
14. 131I-labeled chimeric monoclonal antibody G250. J. Clin. Oncol., 15: 1529-1537, 1997.
15. Kranenborg, M. H. G. C., Boerman, O. C., Oosterwijk-Wakka, J. C., de Weijert, M. C. A., Corstens, F. H. M., and Oosterwijk, E. Development and characterization of anti-renal cell carcinoma X anti-DTPA bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma. Cancer Res 55 (Suppl.).-5864s-5867s, 1995.
16. Esteban, J. M., Schlom, J., Gansow, O. A., Atcher, R. W., Brechbiel, M. W., Simpson, D. E., and Colcher, D. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med., 28: 861-870, 1987.
17. Beniers, A. J. M. C., Peelen, W. P., Schaafsma, H. E., Beck, J. L. M., Ramaekers, F. C. S., Debruyne, F. M. J., and Schalken, J. A. Establishment and characterization of five new human renal tumor xenografts. Am. J. Pathol., 140: 483-495, 1992.
18. Kranenborg, M. H. G. C., Boerman, O. C., de Weijert, M. C. A., Oosterwijk-Wakka, J. C., Corstens, F. H. M., and Oosterwijk, E. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts. Cancer (Phila.), 80: 2390-2397, 1997.
19. Boerman, O. C., Tibben, J. G., Massuger, L. F. A. G., Claessens, R. A. M. J., and Corstens, F. H. M. Tumour targeting of the anti-ovarian carcinoma x anti-CD3/TCR bispecific antibody OC/TR and its parental MOv18 antibody in experimental ovarian cancer. Anticancer Res., 15: 2169-2174, 1996.
20. 90Y radioimmunotherapy. Cancer Res., 54: 5937-5946, 1994.
21. Reardan, D. T., Meares, C. F., Goodwin, D. A., McTigue, M., David, G. S., Stone, M. R., Leung, J. P., Bartholomew, R. M., and Frincke, J. M. Antibodies against metal chelates. Nature (Lond.), 316: 265-268, 1985.
22. Feng, X., Pak, R. H., Kroger, L. A., Moran, J. K., DeNardo, D. G., Meares, C. F., DeNardo, G. L., and DeNardo, S. J. New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor. Hybridoma, 17: 125-132, 1998.
23. Le Doussal, J-M., Chetanneau, A., Gruaz-Guyon, A., Martin, M., Gaulherot, E., Lehur, P-A., and Chatal, J-F. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. J. Nucl. Med., 34: 1662-1671, 1993.
24. Janevik-Ivanovska, E., Gautherol, E., Hillairet de Boisferon, M., Cohen, M., Milhaud, G., Tartar, A., Rostene, W., Barbet, J., and Gruaz-Guyon, A. Bivalent hapten-bearing peplides designed for iodine-131 pretargeted radioimmunotherapy. Bioconjug. Chem., 8: 526-533, 1997.
25. Goodwin, D. A., Meares, C. F., Mc Tigue, M., Chaovapong, W., Diamanti, C. I., Ransone, C. H., and McCall, M. J. Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. J. Nucl. Med., 33: 2006-2013, 1992.
26. Le Doussal, J. M., Martin, M., Gautherot, E., Delaage, M., and Barbet, J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cellbound antibody conjugate. J Nucl. Med., 30: 1358-1366, 1989.
27. Sharkey, R. M., Boerman, O. C., Natale, A., Pawlyk, D., Monestier, M., Losman, M. J., and Goldenberg, D. M. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice. Int. J. Cancer, 51: 266-273, 1992.
28. Duncan, J. R., and Welch, M. J. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J Nucl. Med., 34: 1728-1738, 1993.
29. 125I-labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. Cancer Biother. Radiopharm., 13: 133-139, 1998.
30. Paganelli, G., Belloni, C., Magnani, P., Zito, F., Pasini, A., Sassi, I., Meroni, M., Mariani, M., Vignali, M., Sicardi, A. G., and Fazzio, F. Two-step tumour targetting in ovarian cancer patients using biotinylaled monoclonal antibodies and radioactive streptavidin. Eur. J. Nucl. Med., 19: 322-329, 1992.
31. 90Y delivery to mouse tumor xenografts. Tumor Targeting, 2: 156-157, 1996.
32. Paganelli, G., Grana, C., Chinol, M., Cremonesi, M., DeCicco, C., De Braud, F., Robertson, C., Zurrida, S., Casadio, C., Zoboli, S., Siccardi, A. G., and Veronesi, V. Antibody-guided three-slep therapy for high grade glioma with yttrium-90 biotin. Eur. J. Nucl. Med., 26: 348-357, 1999.